MDC Pharmaceuticals Ltd - Stock Valuation and Financial Performance

BSE: 0 | NSE: | Pharmaceuticals & Drugs | Small Cap

BSE Share Price
Not Listed

DeciZen - make an informed investing decision on MDC Pharmaceuticals

DeciZen not available for IPO

10 Year X-Ray of MDC Pharmaceuticals:

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.

Value Creation

Value Creation Index Colour Code Guide

Mar'13Mar'14Mar'15Mar'16Mar'17TTM
ROCE % 8.7%11.8%5.4%8.3%15.8%-

Growth Parameters

Growth Parameters Colour Code Guide

Sales 34.535.94147.647.648
Sales YoY Gr.-4.2%14.1%16.1%0.1%-
Adj EPS 0.71.40.30.92.42.3
YoY Gr.-107.4%-79.4%210.3%167.8%-
BVPS (₹) 10.311.712.113.215.626.4
Adj Net
Profit
0.81.70.41.12.90
Cash Flow from Ops. 3.22.78.73.94.2-
Debt/CF from Ops. 3.53.80.92.10.7-

CAGR

CAGR Colour Code Guide

9 Years 5 Years 3 Years 1 Years
Sales NANA9.8%0.1%
Adj EPS NANA19.6%167.8%
BVPSNANA10.3%18.5%
Share Price - - - -

Key Financial Parameters

Performance Ratio Colour Code Guide

Mar'13Mar'14Mar'15Mar'16Mar'17TTM
Return on
Equity %
6.612.92.47.116.810.9
Op. Profit
Mgn %
10.5137.38.413.8NAN
Net Profit
Mgn %
2.44.70.82.36.10
Debt to
Equity
0.90.70.50.50.2-
Working Cap
Days
01861721451500
Cash Conv.
Cycle
013010782840

Recent Performance Summary

Recent Performance Summary not available for IPO

Recent Performance Summary not available for IPO

Latest Financials - MDC Pharmaceuticals Ltd.

Standalone Consolidated
TTM EPS (₹) 2.3 -
TTM Sales (₹ Cr.) 47.6 -
BVPS (₹.) 26.4 -
Reserves (₹ Cr.) 21 -
P/BV 0.00 -
PE 0.00 -
From the Market
52 Week Low / High (₹) 0.00 / 0.00
All Time Low / High (₹) - / -
Market Cap (₹ Cr.) 0
Equity (₹ Cr.) 0
Face Value (₹) 10
Industry PE 48.8

Management X-Ray of MDC Pharmaceuticals:

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged *0.00
* Pledged shares as % of Promoter's holding (%)

Event Update

Login/Register to view analysis.

Analyst's Notes

Key Ratios of MDC Pharmaceuticals

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Profit And Loss

(All Figures are in Crores.)
PARTICULARSMar'13Mar'14Mar'15Mar'16Mar'17
Sales34.4835.9440.9947.5747.60
Operating Expenses 30.8731.263843.5841.04
Manufacturing Costs1.311.211.321.641.32
Material Costs25.2924.9328.7330.8828.58
Employee Cost 3.554.076.609.079.72
Other Costs 0.721.051.341.981.42
Operating Profit 3.624.682.9946.56
Operating Profit Margin (%) 10.5%13.0%7.3%8.4%13.8%
Other Income 0.170.020.290.290.05
Interest 1.811.631.281.160.99
Depreciation 0.860.951.421.021.14
Exceptional Items 00000
Profit Before Tax 1.122.120.582.104.49
Tax 0.200.420.040.821.56
Profit After Tax 0.931.700.551.282.93
PAT Margin (%) 2.7%4.7%1.3%2.7%6.1%
Adjusted EPS (₹)0.81.40.51.12.4
Dividend Payout Ratio (%)0%0%0%0%0%

Balance Sheet

(All Figures are in Crores.)
PARTICULARSMar'13Mar'14Mar'15Mar'16Mar'17

Equity and Liabilities

Shareholders Fund 12.3114.0114.5615.8418.76
Share Capital 22222
Reserves 10.3112.0112.5613.8416.76
Minority Interest00000
Debt10.799.626.247.122.10
Long Term Debt3.953.493.913.152.10
Short Term Debt6.846.122.333.970
Trade Payables0.770.875.085.026
Others Liabilities 2.252.744.083.956.31
Total Liabilities 26.1127.2329.9631.9233.17

Fixed Assets

Gross Block12.5213.9014.1316.3218.07
Accumulated Depreciation6.717.669.089.6810.81
Net Fixed Assets5.816.245.056.637.27
CWIP 00000.93
Investments 2.881.375.352.632.28
Inventories6.656.598.429.5713.07
Trade Receivables6.937.277.846.586.74
Cash Equivalents 0.160.290.174.140.27
Others Assets3.685.463.132.352.62
Total Assets 26.1127.2329.9631.9233.17

Cash Flow

(All Figures are in Crores.)
PARTICULARSMar'13Mar'14Mar'15Mar'16Mar'17
Cash Flow From Operating Activity 3.242.718.683.874.22
PBT 1.122.120.582.104.49
Adjustment 2.702.472.741.941.91
Changes in Working Capital -0.42-1.536.060.08-1.56
Tax Paid -0.16-0.34-0.70-0.25-0.62
Cash Flow From Investing Activity -0.810.13-4.240.21-2.37
Capex -0.55-1.38-0.23-2.46-2.68
Net Investments -0.181.51-3.972.710.36
Others -0.080-0.04-0.04-0.05
Cash Flow From Financing Activity -2.37-2.71-4.57-0.11-5.72
Net Proceeds from Shares 00000
Net Proceeds from Borrowing -1.67-0.450.41-0.76-1.05
Interest Paid -1.73-1.54-1.19-0.98-0.70
Dividend Paid 00000
Others 1.02-0.72-3.791.64-3.97
Net Cash Flow 0.060.13-0.123.97-3.87
PARTICULARSMar'13Mar'14Mar'15Mar'16Mar'17
Ratios
ROE (%)7.5312.933.838.4416.91
ROCE (%)12.3515.578.0214.2424.08
Asset Turnover Ratio1.321.351.431.541.53
PAT to CFO Conversion(x)3.481.5915.783.021.44
Working Capital Days
Receivable Days7372675549
Inventory Days7067676983
Payable Days1112386070

MDC Pharmaceuticals Ltd Stock News

MDC Pharmaceuticals Ltd FAQs

Company share prices are keep on changing according to the market conditions. The closing price of MDC Pharmaceuticals on 01-Jan-1970 05:30 is ₹0.00.
Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 01-Jan-1970 05:30 the market cap of MDC Pharmaceuticals stood at ₹0.00.
The latest P/E ratio of MDC Pharmaceuticals as of 01-Jan-1970 05:30 is 0.00.
The latest P/B ratio of MDC Pharmaceuticals as of 01-Jan-1970 05:30 is 0.00.
The 52-week high of MDC Pharmaceuticals is ₹0.00 and the 52-week low is ₹0.00.
The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of MDC Pharmaceuticals is ₹47.60 ( Cr.) .

About MDC Pharmaceuticals Ltd

No data to display
You have 0 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.